Search
Menu
Rocky Mountain Instruments - Infrared Optics LB

Bausch & Lomb Zyoptix System Gets FDA Nod

Facebook X LinkedIn Email
ROCHESTER, N.Y., June 4 -- The US Food and Drug Administration (FDA) has accepted Bausch & Lomb's modular premarket approval application (PMA) for its Zyoptix system for customized vision correction, the company announced. Bausch & Lomb chairman and CEO Ronald L. Zarrella said, "With our Zyoptix system, Bausch & Lomb was the first company to offer refractive surgeons and their patients truly personalized laser vision correction technology in Europe, Asia, Latin America and Canada. Our PMA submission to the FDA is a key step toward bringing this advanced technology into the important US...Read full article

Related content from Photonics Media

    Published: June 2002
    News & Features

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.